Literature DB >> 19364625

It's not just what you say, it's also how you say it: opening the 'black box' of informed consent appointments in randomised controlled trials.

Julia Wade1, Jenny L Donovan, J Athene Lane, David E Neal, Freddie C Hamdy.   

Abstract

Randomised controlled trials (RCTs) represent the gold standard methodology for determining effectiveness of healthcare interventions. Poor recruitment to RCTs can threaten external validity and waste resources. An inherent tension exists between safeguarding informed decision-making by participants and maximising numbers enrolled. This study investigated what occurs during informed consent appointments in an ongoing multi-centre RCT in the UK. Objectives were to investigate: 1] how study staff presented study information to participants; 2] what evidence emerged as to how well-informed participants were when proceeding to randomisation or treatment selection; and 3] what aspects of the communication process may facilitate improvements in providing evidence of informed consent. Qualitative analysis of a purposive sample of 23 recruitment appointments from three study centres and involving several recruitment staff applied techniques of thematic, content and conversation analysis (CA). Thematic analysis and CA revealed variation in appointment content and structure. Appointments were mostly recruiter-led or participant-led, and this structure was associated with what evidence emerged as to how participants understood information provided and whether they were in equipoise. Participant-led appointments provided this evidence more consistently. Detailed CA identified communication techniques which, when employed by recruiters, provided evidence as to how participants understood the choices before them. Strategic use of open questions, pauses and ceding the floor in the interaction facilitated detailed and systematic exploration of each participant's concerns and position regarding equipoise. We conclude that the current focus on content to be provided to achieve informed consent should be broadened to encompass consideration of how information is best conveyed to potential participants. A model of tailored information provision using the communication techniques identified and centred on eliciting and addressing participants' concerns is proposed. Use of these techniques is necessary to make potential participants' understanding of key issues and their position regarding equipoise explicit in order to facilitate truly informed consent.

Entities:  

Mesh:

Year:  2009        PMID: 19364625     DOI: 10.1016/j.socscimed.2009.02.023

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  67 in total

1.  Stem cell clinical trials for spinal cord injury: readiness, reluctance, redefinition.

Authors:  J Illes; J C Reimer; B K Kwon
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

2.  Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs.

Authors:  Christine Hemming; Lynda Constable; Beatriz Goulao; Mary Kilonzo; Dwayne Boyers; Andrew Elders; Kevin Cooper; Anthony Smith; Robert Freeman; Suzanne Breeman; Alison McDonald; Suzanne Hagen; Isobel Montgomery; John Norrie; Cathryn Glazener
Journal:  Health Technol Assess       Date:  2020-03       Impact factor: 4.014

3.  Power of an effective clinical conversation: improving accrual onto clinical trials.

Authors:  Linda K Parreco; Rhonda W DeJoice; Holly A Massett; Rose Mary Padberg; Sona S Thakkar
Journal:  J Oncol Pract       Date:  2012-03-27       Impact factor: 3.840

4.  Patch augmentation surgery for rotator cuff repair: the PARCS mixed-methods feasibility study.

Authors:  Jonathan A Cook; Mathew Baldwin; Cushla Cooper; Navraj S Nagra; Joanna C Crocker; Molly Glaze; Gemma Greenall; Amar Rangan; Lucksy Kottam; Jonathan L Rees; Dair Farrar-Hockley; Naomi Merritt; Sally Hopewell; David Beard; Michael Thomas; Melina Dritsaki; Andrew J Carr
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

5.  Improving informed consent: Stakeholder views.

Authors:  Emily E Anderson; Susan B Newman; Alicia K Matthews
Journal:  AJOB Empir Bioeth       Date:  2017-08-02

6.  Open urethroplasty versus endoscopic urethrotomy for recurrent urethral stricture in men: the OPEN RCT.

Authors:  Robert Pickard; Beatriz Goulao; Sonya Carnell; Jing Shen; Graeme MacLennan; John Norrie; Matt Breckons; Luke Vale; Paul Whybrow; Tim Rapley; Rebecca Forbes; Stephanie Currer; Mark Forrest; Jennifer Wilkinson; Elaine McColl; Daniela Andrich; Stewart Barclay; Jonathan Cook; Anthony Mundy; James N'Dow; Stephen Payne; Nick Watkin
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

7.  STRATEGIES TO ENHANCE RECRUITMENT METHODS IN PHANTOM LIMB PAIN CLINICAL TRIALS.

Authors:  Camila Bonin Pinto; Faddi Ghassan Saleh Vélez; Melanie N French; Dian Zeng; David Crandell; Nadia Bolognini; Lotfi B Merabet; Felipe Fregni
Journal:  Int J Clin Trials       Date:  2017 Apr-Jun

8.  Reasons for participating in randomised controlled trials: conditional altruism and considerations for self.

Authors:  Sharon K McCann; Marion K Campbell; Vikki A Entwistle
Journal:  Trials       Date:  2010-03-22       Impact factor: 2.279

9.  Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.

Authors:  Richard E Appleton; Naomi Ea Rainford; Carrol Gamble; Shrouk Messahel; Amy Humphreys; Helen Hickey; Kerry Woolfall; Louise Roper; Joanne Noblet; Elizabeth Lee; Sarah Potter; Paul Tate; Nadia Al Najjar; Anand Iyer; Vicki Evans; Mark D Lyttle
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

10.  The recruitment of patients to trials in head and neck cancer: a qualitative study of the EaStER trial of treatments for early laryngeal cancer.

Authors:  D W Hamilton; I de Salis; J L Donovan; M Birchall
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-20       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.